knowledge -WSS

knowledge

author：comprehensive 2025-10-02 00:53:44 - browse：25

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： CDC launches VaccineFinder tool to locate Covid

hotspot

WSS

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Key Senate panel to consider PBM, drug pricing reform package

The health care issue Democrats can’t solve: hospital reform

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Judge rejects Trump's counterclaim against E. Jean Carroll

After Sarepta trial failure, Duchenne families brace for more debate

hotspot

knowledge

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Life sciences investors close nearly $6 billion in new funds

As demand for Covid shots wanes, Moderna seeks its next success

Judge rejects Trump's counterclaim against E. Jean Carroll

Activists slam private health insurers over coverage restrictions

Explaining an after

Walensky prepares to leave CDC — and Congress — behind

Gene therapy’s promise and the high cost of hope

Moonlake's readout produced a cash windfall. Risks remain

In venture capital firm's success, lessons for turning crisis into profit

knowledge

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

‘The Bear’ and hospitality in hospitals

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Germany receives 178 compensation applications from gay servicepeople over discrimination

Zapping the brain for stroke rehab: Pivotal clinical trial begins

knowledge

leisure time

hotspot

explore